Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug ...

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration. This groundbreaking study, ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The Virtual Investor “What This Means” segment featuring Outlook Therapeutics is now available here.

Optometry professionals have welcomed plans to tackle waiting lists, and highlighted the skills, experience, and equipment of ...

Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal ...

2025 has started on a promising footing. Inflation seems to be moderating, global rates are finally falling, and there are ...

Maintaining optimal eye health has become more crucial in today’s fast-paced world. With the rise of digital screens and ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...